Evaluation of a new atropine-brand anticholinergic; clinical, gastric secretory and roentgenological effects in peptic ulcer and gastrointestinal functional disorders.
D000863:Antacids / Q000627:therapeutic use*; D001285:Atropine; D001286:Atropine Derivatives; D018680:Cholinergic Antagonists; D005767:Gastrointestinal Diseases / Q000628:therapy*; D006801:Humans; D010437:Peptic Ulcer / Q000628:therapy*; D014815:Vitamins / Q000627:therapeutic use*
D000863:Antacids; D001286:Atropine Derivatives; D018680:Cholinergic Antagonists; D014815:Vitamins; D001285:Atropine
ANTACIDS/therapeutic use; ATROPINE/derivatives; GASTROINTESTINAL DISEASES/therapy; PEPTIC ULCER/therapy; VITAMINS/therapeutic use